EUVIMEDEUVIMED entdecken
Open Access

Projected Trends in Metabolic Dysfunction–Associated Steatotic Liver Disease Mortality Through 2040

Xinrong Zhang, Sovann Linden, Charles R Levesley, Xinyuan He, Zhanpeng Yang, Scott D Barnet, Ramsey Cheung, Fanpu Ji, Mindie H Nguyen

JAMA Network Open · 17.06.2025 · 8 (6) · e2516367

DOI: 10.1001/jamanetworkopen.2025.16367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 17.06.2025. Verfasst von Xinrong Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Population-based data for metabolic dysfunction–associated steatotic liver disease (MASLD)–related mortality trends and forecasts in the United States are limited.

Objective

To examine MASLD-related mortality trends in the United States from 2006 to 2023 and forecast mortality rates up to 2040 overall and in subgroups by age, sex, race and ethnicity, and urbanization. Design, Setting, and Participants This cross-sectional study used data from the National Vital Statistics System dataset. Data on deaths attributed to MASLD were obtained for adults aged 25 years and older from January 1, 2006, to December 31, 2023. Main Outcomes and Measures Trends were evaluated by average annual percentage change (AAPC) in age-standardized mortality rates (ASMRs) per 100 000 persons, and mortality rates were forecasted to 2040 using projection models.

Results

A total of 27 961 decedents aged 25 years and older with MASLD (15 251 [54.5%] aged ≥65 years; 15 450 [55.3%] female; 3373 [12.1%] Hispanic, 1480 [5.3%] non-Hispanic Black, and 21 936 [78.5%] non-Hispanic White) were documented from 2006 to 2023. ASMRs rose from 0.25 to 1.27 per 100 000 persons, with AAPCs increasing from 9.27% in 2006 to 2018 to 22.66% in 2018 to 2021, then decreasing to −1.23% from 2021 to 2023, leading to projected ASMRs of 2.24 per 100 000 persons in 2040. There were significant differences in the increases of ASMRs by age, with those aged 65 years or older having the steepest rise (AAPC, 15.34%; 95% CI, 14.40%-16.32%; P < .001; 45-64 years: 8.76%; 95% CI, 7.29%-10.22%; P < .001; 25-44 years: 2.65%; 95% CI, 0.49%-4.86%; P = .02) and a projected increase from 3.69 per 100 000 persons in 2024 to 7.12 per 100 000 persons in 2040. However, there was no significant difference in ASMRs by sex (AAPC among women: 11.24%; 95% CI, 10.09%-12.40%; P < .001; AAPC among men: 11.04%; 95% CI, 9.56%-12.63%; P < .001). ASMRs rose for all major racial ethnic groups, with the highest ASMR increase observed for non-Hispanic White individuals (AAPC, 11.12%; 95% CI, 9.48%-12.83%; P < .001), followed by Hispanic (AAPC, 10.67%; 95% CI, 9.11%-12.26%; P < .001), non-Hispanic Black (AAPC, 9.20%; 95% CI, 7.32%-11.11%; P < .001), and non-Hispanic Asian (AAPC, 7.97%; 95% CI, 4.66%-11.75%; P < .001) individuals, while the projected values for these 4 groups showed similar increasing trends to 2040. There were also significant differences in ASMRs by metropolitan categories overall, with the highest rise in nonmetropolitan areas (AAPC, 13.50%; 95% CI, 10.70%-16.32%; P < .001). Conclusions and Relevance In this cross-sectional study, MASLD-related mortality increased rapidly between 2006 and 2023 and was projected to rise over the next 20 years, with the largest disparities among those aged 65 years and older, among non-Hispanic White and Hispanic individuals, and among nonmetropolitan populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverHumansFemaleMaleMiddle AgedAdultCross-Sectional StudiesUnited StatesAgedForecastingMortalityAged, 80 and over

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California.
  • Department of Management Science and Engineering, School of Engineering, Stanford University, Palo Alto, California.
  • Department of Biology, Stanford University, Palo Alto, California.
  • Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, China.
  • Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

Zitieren

APA

Zhang, X., Linden, S., Levesley, C. R., He, X., Yang, Z., Barnet, S. D., Cheung, R., Ji, F., & Nguyen, M. H. (2025). Projected Trends in Metabolic Dysfunction–Associated Steatotic Liver Disease Mortality Through 2040. JAMA Network Open, 8(6), e2516367. https://doi.org/10.1001/jamanetworkopen.2025.16367

Vancouver

Zhang X, Linden S, Levesley CR, He X, Yang Z, Barnet SD, et al. Projected Trends in Metabolic Dysfunction–Associated Steatotic Liver Disease Mortality Through 2040. JAMA Network Open. 2025;8(6):e2516367. doi:10.1001/jamanetworkopen.2025.16367

BibTeX
@article{Zhang2025,
  author = {Zhang, Xinrong and Linden, Sovann and Levesley, Charles R and He, Xinyuan and Yang, Zhanpeng and Barnet, Scott D and Cheung, Ramsey and Ji, Fanpu and Nguyen, Mindie H},
  title = {Projected Trends in Metabolic Dysfunction–Associated Steatotic Liver Disease Mortality Through 2040},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {6},
  pages = {e2516367},
  doi = {10.1001/jamanetworkopen.2025.16367}
}
Kostenlos starten →